Primer: Dazhong Dental Medical (2651 HK) - Aug 2026
Dazhong Dental is a regionally focused private dental service provider in Central China, primarily Hubei province, facing a dynamic but...
98 Views
APAC Healthcare Weekly (March 29) – Hansoh, CSPC, Chugai, Takeda, Otsuka, Celltrion, Alteogen
Hansoh got trial approval, while CSPC obtained new drug approval. Chugai’s partner is discontinuing development of emugrobart. Otsuka is acquiring...
336 Views
Wuhan Dazhong Dental Medical IPO: Shine Revival Will Take a Few Sessions
Wuhan Dazhong Dental launched IPO aiming to raise $30M. The company plans to sell 10.8M shares at HK$20–21.4 per share. Share subscriptions will...
474 Views
Pre-IPO Wuhan Dazhong Dental Medical - Valuation Performance May Disappoint Investors
To attract top dentists, dental service providers have to pay higher salaries, impacting profit margins. VBP will affect revenue growth for...
818 Views
No more insights